Revisi per 9 Januari 2023 12.53 sunting Arya-Bot (bicara \| kontrib) Bot, Pengecualian blokir IP 261.428 suntingan k →top: clean up Tag: AWB ← Revisi sebelumnya		Revisi per 16 Juni 2023 01.13 sunting balikkan InternetArchiveBot (bicara \| kontrib) Bot 695.054 suntingan Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5 Revisi selanjutnya →
Baris 29: \| KEGG_Ref = {{keggcite\|correct\|kegg}} \| KEGG = D04603 \| synonyms = BMS-734016,<ref>{{cite web\|title=Yervoy, ipilimumab (BMS-734016) - Product Profile - BioCentury\|url=http://www.biocentury.com/products/bms-734016\|website=BioCentury Online Intelligence\|publisher=BioCentury Publications\|accessdate=11 August 2016\|archive-date=2016-08-12\|archive-url=https://web.archive.org/web/20160812100312/http://www.biocentury.com/products/bms-734016\|dead-url=yes}}</ref> MDX-010,<ref>{{cite press release \| url = http://www.ama-assn.org/resources/doc/usan/ipilimumab2.doc \| title = STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL - ipilimumab \| author = USAN \| publisher = [[American Medical Association]] (AMA) \| accessdate = 2013-01-12 }} {{~~Webarchive~~Cite web \|url=http://www.ama-assn.org/resources/doc/usan/ipilimumab2.doc \|title=Salinan arsip \|access-date=2016-11-29 \|archive-date=2016-02-23 \|archive-url=https://web.archive.org/web/20160223223857/http://www.ama-assn.org/resources/doc/usan/ipilimumab2.doc \|~~date=2016~~dead-~~02-23~~url=yes }}</ref> MDX-101 <!-- Chemical data --> \| C=6742 \| H=9972 \| N=1732 \| O=2004 \| S=40

Ipilimumab: Perbedaan antara revisi